Epidemiology and prognosis of anti-infective therapy in the ICU setting during acute pancreatitis: a cohort study.
Philippe MontraversElie KantorJean-Michel ConstantinJean-Yves LefrantThomas LescotNicolas NesselerCatherine PaugamMatthieu JabaudonHervé DupontPublished in: Critical care (London, England) (2019)
High proportions of ICU patients admitted for AP receive AIT, both on admission and during their ICU stay. A large heterogeneity was observed between centres in terms of incidence of infections, AIT prescribing practices, therapeutic management and outcome. AIT reflects the initial severity and complications of AP, but is not a risk factor for death.